Clinical trials with ST-segment elevation myocardial infarction

Clinical trials with ST-segment elevation myocardial infarction.

Anticoagulation for ST-segment elevation myocardial infarction.

Adjunctive anticoagulant therapy reduces the risk of recurrent infarction and death in patients with STsegment elevation myocardial infarction (STEMI) receiving fibrinolytic therapy.1–5 Unfractionated heparin (UFH), the first anticoagulant evaluated for this indication,1 continues to be used because of its predominantly nonrenal clearance, short half-life, reversibility, and the familiarity of ...

False Positive ST-Segment Elevation Myocardial Infarction

Acute ST-segment elevation myocardial infarction (STEMI) is a serious disease in clinical practice. The rapid and accurate diagnosis of this critical illness can lead to prompt reperfusion, and it enables the reduction of cardiac ischemic damage and results in improved subsequent outcomes. The shorter the time to reperfusion, the greater the benefits. The American College of Cardiology/American...

ST-Segment Elevation in Acute Myocardial Infarction

Four hundred and four patients who were admitted to the hospital with their first myocardial infarction within 24 hours of the onset of symptoms were studied. In 315 patients the ECG findings in 12 standards leads (I, II, aVF, aVR, aVL, V,-V6) showed the infarction to be in the anterior wall, the inferior wall, or in multiple areas. The patients in each of these three categories were further su...

Study of the Duration, Outcomes, and Related Factors of Reperfusion Therapy in Patients with ST-Segment Elevation Myocardial Infarction

Background and Objective: One of the most important advancements regarding the care of patients with acute myocardial infarction is the administration of anti-coagulation medicines (e.g., streptokinase). However, it must be noticed that this medicine requires rapid and timely administration. Moreover, Percutaneous Coronary Intervention (PCI) is increasingly used as a method of revascularization...